Abstract
Inflammation has a pivotal role in cardiac remodeling, and circulating biomarkers of inflammation are independently associated with risk of developing heart failure and with prognosis after onset of the condition. Pentraxin 3 has been suggested as a novel biomarker of left ventricular diastolic dysfunction and heart failure with normal ejection fraction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 246-248 |
| Number of pages | 3 |
| Journal | Nature Reviews Cardiology |
| Volume | 8 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2011 |
| Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine